Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | IDH2 | P48735 | 2/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.31 |
| ▸ | CCR5 | P51681 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.30 |
| ▸ | FKBP4 | Q02790 | 1/20 | 0.30 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.30 |
| ▸ | YAP1 | P46937 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6809311 | 1.00 | PTGER4 (0.34) | PTGER4IDH2ADRB3CCR5HTR2C | |
| SCHEMBL6804277 | 0.89 | PTGER4 (0.34) | PTGER4IDH2ADRB3CCR5POLB | |
| SCHEMBL6804273 | 0.89 | PTGER4 (0.34) | PTGER4IDH2ADRB3CCR5POLB | |
| SCHEMBL6270623 | 0.89 | PTGER4 (0.38) | PTGER4IDH2ADRB3CCR5HTR2C | |
| SCHEMBL6804852 | 0.88 | PTGER4 (0.33) | PTGER4IDH2ADRB3CCR5POLB | |
| SCHEMBL6804860 | 0.88 | PTGER4 (0.33) | PTGER4IDH2ADRB3CCR5POLB | |
| SCHEMBL6269059 | 0.88 | PTGER4 (0.35) | PTGER4IDH2ADRB3CCR5FKBP1A | |
| SCHEMBL6802975 | 0.88 | PTGER4 (0.37) | PTGER4IDH2ADRB3CCR5FKBP1A | |
| SCHEMBL6802969 | 0.88 | PTGER4 (0.37) | PTGER4IDH2ADRB3CCR5FKBP1A | |
| SCHEMBL6676570 | 0.87 | PTGER4 (0.33) | PTGER4ADRB3CCR5POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | PTGER4 1794/4885IDH2 929/4885ADRB3 150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.